최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pediatric infection and vaccine: PIV, v.26 no.3, 2019년, pp.140 - 147
조용선 (차의과학대학교 분당차병원 소아청소년과) , 이신혜 (차의과학대학교 분당차병원 소아청소년과) , 이택진 (차의과학대학교 분당차병원 소아청소년과)
Purpose: Staphylococcus aureus is a major cause of skin and soft tissue infections (SSTIs). This study aimed to determine the temporal trends in antibiotic susceptibility of S. aureus in SSTI patients aged <19 years. Methods: This retrospective observational study was conducted in pediatric patients...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
황색포도알균이란 무엇인가? | 황색포도알균(Staphylococcus aureus)은 피부 및 연조직 감염(skin and soft tissue infections [SSTIs])의 주요 원인이다. 1) 또한 메티실린내성 황색포도알균(methicillin-resistant S. | |
oxacillin 감수성의 연도별 증가 경향은? | 2010년부터 2018년까지 분리된 황색포도알균의 ciprofloxacin, clindamycin, erythromycin, gentamicin, oxacillin, penicillin, tetracycline, TMP/SMX 및 fusidic acid의 연도별 항생제 감수성 은 Table 2와 같다. 연구 기간 동안 oxacillin 감수성은 전반적으로 증가하여(P<0.001), 2010년 58.7%에서 2013년 50.4%까지 감소하였다가 2018년 75.0%까지 꾸준히 증가하였다. Erythromycin 감수성은 2010년 49. | |
CA-MRSA의 유병률과 유전학적 특성으로 국내의 특징은 무엇인가? | CA-MRSA의 유병률과 유전학적 특성은 지리적인 위치에 따라 다르다. 4) 국내의 경우 Ma 등5) 이 2003–2005년 경남 지역에서 분리된 CA-MRSA 23균주를 대상으로 시행한 유전형 분석에 서 ST72와 ST89가 주요 유전형으로 나타나, USA300-ST8가 주된 유전형인 미국과 차이가 있음을 보고하였다. 하지만 2009년 지역사회관련 황색포도알균 감염에서 메티실린 내성율을 30. |
Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007;57:7-13.
Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009;15:1516-8.
Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008;51:291-8.
Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis 2013;13:698-708.
Ma SH, Lee YS, Lee SH, Kim HK, Jin JS, Shin EK, et al. Meticillin-resistant Staphylococcus aureus clones with distinct clinical and microbiological features in a Korean community. J Med Microbiol 2007;56:866-8.
Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F, et al. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 2005;55:379-82.
Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007;13:1840-6.
Landrum ML, Neumann C, Cook C, Chukwuma U, Ellis MW, Hospenthal DR, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012;308:50-9.
Sutter DE, Milburn E, Chukwuma U, Dzialowy N, Maranich AM, Hospenthal DR. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics 2016;137:e20153099.
Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012;67:802-9.
European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance (EARS-Net). In: ECDC. Annual epidemiological report for 2014. Stockholm: ECDC, 2018:1-14.
Moon HW, Kim HJ, Hur M, Yun YM. Antimicrobial susceptibility profiles of Staphylococcus aureus isolates classified according to their origin in a tertiary hospital in Korea. Am J Infect Control 2014;42:1340-2.
Kim ES, Kim HB, Kim G, Kim KH, Park KH, Lee S, et al. Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea. PLoS One 2014;9:e114127.
Baek YS, Jeon J, Ahn JW, Song HJ. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea. Int J Dermatol 2016;55:e191-7.
Shin SM, Shin JY, Kim MH, Lee SH, Choi S, Park BJ. Prevalence of antibiotic use for pediatric acute upper respiratory tract infections in Korea. J Korean Med Sci 2015;30:617-24.
Park JM, Jo JH, Jin H, Ko HC, Kim MB, Kim JM, et al. Change in antimicrobial susceptibility of skin-colonizing Staphylococcus aureus in Korean patients with atopic dermatitis during ten-year period. Ann Dermatol 2016;28:470-8.
Hwang Y, Kang JS, Kim BK, Kim SW. Colonization of Staphylococcus aureus and sensitivity to antibiotics in children with atopic dermatitis. Allergy Asthma Respir Dis 2017;5:21-6.
Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005;24:457-8.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014;59:147-59.
Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics 2010;125:e1294-300.
Khamash DF, Voskertchian A, Tamma PD, Akinboyo IC, Carroll KC, Milstone AM. Increasing clindamycin and trimethoprim-sulfamethoxazole resistance in pediatric Staphylococcus aureus infections. J Pediatric Infect Dis Soc 2019;8:351-3.
Song YK, Han N, Kim MG, Chang HJ, Sohn HS, Ji E, et al. A national pharmacoepidemiological study of antibiotic use in Korean paediatric outpatients. Arch Dis Child 2017;102:660-6.
Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 2009;123:e297-304.
Williams DJ, Cooper WO, Kaltenbach LA, Dudley JA, Kirschke DL, Jones TF, et al. Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections. Pediatrics 2011;128:e479-87.
Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med 2015;372:1093-103.
Grossman ER, Walchek A, Freedman H, Flanagan C. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 1971;47:567-70.
Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect 2016;22:416-22.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.